Brief: Neuland Labs Says USFDA Inspection At Pashmylaram Facility Completed With 2 Observations

Neuland Laboratories

07/02/2020 13:35

Feb 7 (Reuters) - Neuland Laboratories Ltd  NEUL.NS :
    * US FDA INSPECTED ONE MANUFACTURING FACILITY AT PASHMYLARAM
SANGAREDDY DISTRICT, FROM FEB 3-7
    * US FDA INSPECTION HAS BEEN COMPLETED WITH TWO OBSERVATIONS
GIVEN
UNDER FORM 483
    * COMPANY HAS ALREADY INITIATED CORRECTIVE AND PREVENTIVE
ACTIONS
FOR OBSERVATIONS

Source text for Eikon:  ID:nBSE24BlNf 
Further company coverage:  NEUL.NS 

 ((Reuters.Briefs@thomsonreuters.com;))